GlaxoSmithKline Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Combination vaccines

Registered for use in people aged ≥1 year.

Hepatitis A and hepatitis B combination vaccine

Each 1.0 mL monodose vial or pre-filled syringe contains:

  • 720 ELISA units of inactivated hepatitis A virus (HM175 strain)
  • 20 µg recombinant hepatitis B surface antigen protein
  • 0.45 mg aluminium as aluminium phosphate and aluminium hydroxide

Also contains traces of:

  • formaldehyde
  • neomycin
  • trometamol
  • polysorbate 20

May contain yeast proteins.

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018


enzyme-linked immunosorbent assay